Keywords:
Diabetic kidney disease; nephrin; chronic kidney disease; podocyte injury; biomarkers; type 2 diabetes mellitus.References
1. Ahmad, M. B., Adamu, A. I., & Sarafa, O. O. (2025). Nephrin: An early biomarker of diabetic nephropathy among type-2 diabetic patients in Kano Metropolis. Sokoto Journal of Medical Laboratory Science, 10(4), 185. https://doi.org/10.4314/sokjmls.v10i4.16
2. Amiruzzaman, M., Islam, M., & Prasad, I. (2025). Correlation of urinary nephrin with albuminuria as early marker of diabetic nephropathy in type 2 diabetes mellitus. Journal of Association of Clinical Endocrinologist and Diabetologist of Bangladesh. https://doi.org/10.3329/jacedb.v4i20.84945
3. Bobkova, I., Щукина, А. А., & Шестакова, М. В. (2017). ASSESSMENT OF NEPHRIN AND PODOCIN LEVELS IN THE URINE OF PATIENTS WITH DIABETES MELLITUS. Nephrology (Saint-Petersburg), 21(2), 33. https://doi.org/10.24884/1561-6274-2017-21-2-33-40
4. Chang, J.-H., Paik, S.-Y., Mao, L., Eisner, W., Flannery, P. J., Wang, L., Tang, Y., Mattocks, N. K., Hadjadj, S., Goujon, J.-M., Ruiz, P., Gurley, S. B., & Spurney, R. F. (2012). Diabetic Kidney Disease in FVB/NJ Akita Mice: Temporal Pattern of Kidney Injury and Urinary Nephrin Excretion. PLoS ONE, 7(4). https://doi.org/10.1371/journal.pone.0033942
5. Chien, H.-Y., Chen, C., Chiu, Y., Lin, Y., & Li, W. (2016). Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan. International Journal of Medical Sciences, 13(6), 457. https://doi.org/10.7150/ijms.15548
6. Chittaragi, G. H., Ambali, A. P., Honnutagi, R., & Ganesh, V. (2024). Role of urinary nephrin to predict early onset of nephropathy in patients with type 2 diabetes mellitus. Panacea Journal of Medical Sciences, 14(2), 497. https://doi.org/10.18231/j.pjms.2024.090
7. Currie, G. (2014). Biomarkers in diabetic nephropathy: Present and future. World Journal of Diabetes, 5(6), 763. https://doi.org/10.4239/wjd.v5.i6.763
8. Ecelbarger, C. (2021). Diabetic Kidney Disease Represents a Locus of Opportunity. Frontiers in Physiology, 12. https://doi.org/10.3389/fphys.2021.650503
9. Fiseha, T. (2015). Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients. Biomarker Research, 3(1). https://doi.org/10.1186/s40364-015-0042-3
10. Fukuda, A., Minakawa, A., Kikuchi, M., Sato, Y., Nagatomo, M., Nakamura, S., Mizoguchi, T., Fukunaga, N., Shibata, H., Naik, A. S., Wiggins, R. C., & Fujimoto, S. (2020). Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathy. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-75320-1
11. Ganesh, V., Murugan, M., Goud, V. GK., & Gangannagari, V. K. (2022). Correlation of urinary nephrin with albubinuria to predict early onset of nephropathy in patients with type 2 diabetes mellitus. International Journal of Health Sciences, 4621. https://doi.org/10.53730/ijhs.v6ns3.6947
12. Gluhovschi, C., Gluhovschi, G., Petrică, L., Timar, R., Velciov, S., Ioniță, I., Kaycsa, A., & Timar, B. (2016). Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy. Journal of Diabetes Research, 2016, 1. https://doi.org/10.1155/2016/4626125
13. Hliel, A. K., Ahmed, H. M., & Abdulhussein, H. (2025a). Comparative Study on Nephrin, Transforming Growth Factor-β and Some Biochemical Markers for Predicting Type 2 Diabetic Nephropathy...مجلة النسور للعلوم الطبية, 7(1), 44. https://doi.org/10.70492/2664-0554.1137
14. Hliel, A. K., Ahmed, H. M., & Abdulhussein, H. (2025b). Estimation of Some Biomarkers in Type 2 Diabetic Patients for Detection Early Incidence of Diabetic Nephropathy. ACTA MEDICA IRANICA. https://doi.org/10.18502/acta.v63i3.19718
15. Ioannou, K. (2018). Diabetic nephropathy: is it always there? Assumptions, weaknesses and pitfalls in the diagnosis [Review of Diabetic nephropathy: is it always there? Assumptions, weaknesses and pitfalls in the diagnosis]. HORMONES, 16(4). Springer Science+Business Media. https://doi.org/10.14310/horm.2002.1755
16. Irena, K., Katerina, T.-T., Sonja, T., Svetlana, C., Goce, S., Ognen, K., & Danica, L. (2020). Urinary nephrin is earlier, more sensitive and specific marker of diabetic nephropathy than microalbuminuria. SHILAP Revista de Lepidopterología. https://doaj.org/article/25d6a83f451149 d08c2bff161902e353
17. Jim, B., Ghanta, M., Qipo, A., Fan, Y., Chuang, P. Y., Cohen, H. W., Abadi, M., Thomas, D. B., & He, J. C. (2012). Dysregulated Nephrin in Diabetic Nephropathy of Type 2 Diabetes: A Cross Sectional Study. PLoS ONE, 7(5). https://doi.org/10.1371/journal.pone.0036041
18. Jim, B., Mehta, S., Cabrera, V. J., & Upputalla, R. (2013). Urinary biomarkers of diabetic nephropathy. Current Biomarker Findings, 67. https://doi.org/10.2147/cbf.s36985
19. Jim, B., Santos, J., Spath, F., & He, J. C. (2012). Biomarkers of Diabetic Nephropathy, the Present and the Future. Current Diabetes Reviews, 8(5), 317. https://doi.org/10.2174/157339 912802083478
20. Kandasamy, Y., Smith, R., Lumbers, E. R., & Rudd, D. (2014). Nephrin – a biomarker of early glomerular injury [Review of Nephrin – a biomarker of early glomerular injury]. Biomarker Research, 2(1). BioMed Central. https://doi.org/10.1186/2050-7771-2-21
21. Kato, M., & Natarajan, R. (2019). Epigenetics and epigenomics in diabetic kidney disease and metabolic memory [Review of Epigenetics and epigenomics in diabetic kidney disease and metabolic memory]. Nature Reviews Nephrology, 15(6), 327. Nature Portfolio. https://doi.org/10.1038/s41581-019-0135-6
22. Khairi, W. Z., & Al-Samarrai, R. R. H. (2025). Evaluation of The Nephrin And Fibroblast Growth Factor-23 As Markers For Kidney Injury in Patients With Type 2 Diabetes Mellitus. International Journal of Applied Biochemistry and Molecular Biology., 0. https://doi.org/10.21608 /ijabmb.2025.400180.1017
23. Kostovska, I., Trajkovska, K. T., Topuzovska, S., Cekovska, S., Spasovski, G., Костовски, О., & Labudovic, D. (2019). Urinary nephrin is earlier, more sensitive and specific marker of diabetic nephropathy than microalbuminuria. Journal of Medical Biochemistry. https://doi.org/10.2478/jomb-2019-0026
24. Kravets, I., & Mallipattu, S. K. (2020). The Role of Podocytes and Podocyte-Associated Biomarkers in Diagnosis and Treatment of Diabetic Kidney Disease. Journal of the Endocrine Society, 4(4). https://doi.org/10.1210/jendso/bvaa029
25. Lee, H. S., Wu, H. H. L., Ponnusamy, A., Alderson, H., & Chinnadurai, R. (2025). Is There a Diagnostic and Prognostic Role for Anti-Nephrin Autoantibodies in Diabetic Nephropathy? Antibodies, 14(1), 25. https://doi.org/10.3390/antib14010025
26. Li, C., & Szeto, C. (2024). Urinary podocyte markers in diabetic kidney disease. Kidney Research and Clinical Practice, 43(3), 274. https://doi.org/10.23876/j.krcp.23.109
27. Li, J., Zheng, S., Ma, C., Chen, X., Li, X., Li, S., Wang, P., Chen, P., Wang, Z., Li, W., & Liu, Y. (2023). Research progress on exosomes in podocyte injury associated with diabetic kidney disease [Review of Research progress on exosomes in podocyte injury associated with diabetic kidney disease]. Frontiers in Endocrinology, 14. Frontiers Media. https://doi.org/10.3389/fendo.2023. 1129884
28. Lioudaki, E., Stylianou, K., Petrakis, I., Kokologiannakis, G., Passam, A., Mikhailidis, D. P., Daphnis, E., & Ganotakis, E. S. (2015). Increased Urinary Excretion of Podocyte Markers in Normoalbuminuric Patients with Diabetes. The Nephron Journals/Nephron Journals, 131(1), 34. https://doi.org/10.1159/000438493
29. Liu, L., Guo, Q., Li, C.-Y., Dong, W., & Sun, G. (2015). Novel Biomarkers for Early Diagnosis and Progression of Diabetic Nephropathy. ARC Journal of Diabetes and Endocrinology, 1(1). https://doi.org/10.20431/2455-5983.0101003
30. Liu, Y., Li, S., Rong, W., Zeng, C., Zhu, X., Chen, Q., Li, L., Liu, Z., & Zen, K. (2020). Podocyte-Released Migrasomes in Urine Serve as an Indicator for Early Podocyte Injury. Kidney Diseases, 6(6), 422. https://doi.org/10.1159/000511504
31. Lu, Y., Liu, D., Feng, Q., & Liu, Z. (2020). Diabetic Nephropathy: Perspective on Extracellular Vesicles [Review of Diabetic Nephropathy: Perspective on Extracellular Vesicles]. Frontiers in Immunology, 11. Frontiers Media. https://doi.org/10.3389/fimmu.2020.00943
32. Mesfine, B. B., Vojisavljevic, D., Kapoor, R., Watson, D., Kandasamy, Y., & Rudd, D. (2023). Urinary nephrin—a potential marker of early glomerular injury: a systematic review and meta-analysis [Review of Urinary nephrin—a potential marker of early glomerular injury: a systematic review and meta-analysis]. Journal of Nephrology, 37(1), 39. Springer Science+Business Media. https://doi.org/10.1007/s40620-023-01585-0
33. Musante, L., Tataruch, D., & Holthöfer, H. (2014). Use and Isolation of Urinary Exosomes as Biomarkers for Diabetic Nephropathy [Review of Use and Isolation of Urinary Exosomes as Biomarkers for Diabetic Nephropathy]. Frontiers in Endocrinology, 5. Frontiers Media. https://doi.org/10.3389/fendo.2014.00149
34. Nagar, A. M. T. E., Metwaly, O. E. A., Nasrallah, A. A. E. M., & Kamel, L. M. M. (2022). Role of Nephrinuria in Early Diagnosis of Type 2 Diabetic Nephropathy at Zagazig University Hospitals. The Egyptian Journal of Hospital Medicine, 87(1), 2113. https://doi.org/10.21608/ejhm. 2022.232829
35. Ng, D. P. K., Tai, B., Tan, E., Leong, H., Nurbaya, S., Lim, X.-L., Chia, K., Wong, C.-S., Lim, W., & Holthöfer, H. (2010). Nephrinuria associates with multiple renal traits in type 2 diabetes. Nephrology Dialysis Transplantation, 26(8), 2508. https://doi.org/10.1093/ndt/gfq738
36. Nishad, R., Tahaseen, V., Kavvuri, R., Motrapu, M., Singh, A., Peddi, K., & Pasupulati, A. K. (2021). Advanced-Glycation End-Products Induce Podocyte Injury and Contribute to Proteinuria. Frontiers in Medicine, 8. https://doi.org/10.3389/fmed.2021.685447
37. Papadopoulou‐Marketou, N., Kanaka‐Gantenbein, C., Marketos, N., Chrousos, G. P., & Papassotiriou, I. (2017). Biomarkers of diabetic nephropathy: A 2017 update. Critical Reviews in Clinical Laboratory Sciences, 54(5), 326. https://doi.org/10.1080/10408363.2017.1377682
38. Pätäri, A., Forsblom, C., Havana, M., Taipale, H., Groop, P., Holthöfer, H., & Group, the F. S. (2003). Nephrinuria in Diabetic Nephropathy of Type 1 Diabetes. Diabetes, 52(12), 2969. https://doi.org/10.2337/diabetes.52.12.2969
39. Petrică, L., Ursoniu, S., Gădălean, F., Vlad, A., Gluhovschi, G., Dumitraşcu, V., Vlad, M., Gluhovschi, C., Velciov, S., Bob, F., Matusz, P., Milaş, O., Secara, A., Suteanu‐Simulescu, A., & Popescu, R. (2017). Urinary podocyte-associated mRNA levels correlate with proximal tubule dysfunction in early diabetic nephropathy of type 2 diabetes mellitus. Diabetology & Metabolic Syndrome, 9(1). https://doi.org/10.1186/s13098-017-0228-y
40. Petrică, L., Vlad, A., Gluhovschi, G., Gădălean, F., Dumitraşcu, V., Gluhovschi, C., Velciov, S., Bob, F., Vlad, M., Popescu, R., Milaş, O., & Ursoniu, S. (2014). Proximal Tubule Dysfunction Is Associated with Podocyte Damage Biomarkers Nephrin and Vascular Endothelial Growth Factor in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study. PLoS ONE, 9(11). https://doi.org/10.1371/journal.pone.0112538
41. Rangaswamaiah, H. (2022). Urinary nephrin linked nephropathy in type-2 diabetes mellitus. Bioinformation, 18(12), 1131. https://doi.org/10.6026/973206300181131
42. Ruilope, L. M., & Morales, E. (2020). Faculty Opinions recommendation of The Role of Podocytes and Podocyte-Associated Biomarkers in Diagnosis and Treatment of Diabetic Kidney Disease. [Data set]. In Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature. https://doi.org/10.3410/f.737697188.793573300
43. Sateesh, R., & Shashidhar, K. N. (2025). Urinary nephrin - An emerging novel biomarker in early detection of diabetic nephropathy: A review. Bioinformation, 21(9), 3123. https://doi.org/10.6026/973206300213123
44. Silambanan, S., Kondapi, K., Kumar, Nl., & Moorthy, S. (2021). A study of association of urinary nephrin with albuminuria in patients with diabetic nephropathy. Indian Journal of Nephrology, 31(2), 142. https://doi.org/10.4103/ijn.ijn_305_19
45. Simpson, K., Wonnacott, A., Fraser, D., & Bowen, T. (2016). MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy [Review of MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy]. Current Diabetes Reports, 16(3). Springer Science+Business Media. https://doi.org/10.1007/s11892-016-0724-8
46. Sulaiman, M. K. (2019). Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management [Review of Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management]. Diabetology & Metabolic Syndrome, 11(1). BioMed Central. https://doi.org/10.1186/s13098-019-0403-4
47. Uwaezuoke, S. N. (2017). The role of novel biomarkers in predicting diabetic nephropathy: a review. International Journal of Nephrology and Renovascular Disease, 221. https://doi.org/ 10.2147/ijnrd.s143186
48. Veluri, G., & Mannangatti, M. (2022). Urinary Nephrin is a Sensitive Marker to Predict Early Onset of Nephropathy in Type 2 Diabetes Mellitus. Journal of Laboratory Physicians, 14(4), 497. https://doi.org/10.1055/s-0042-1757718
49. Wang, C., Li, C., Gong, W., & Lou, T. (2013). New urinary biomarkers for diabetic kidney disease. Biomarker Research, 1(1). https://doi.org/10.1186/2050-7771-1-9
50. Wolf, G., Chen, S., & Ziyadeh, F. N. (2005). From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease [Review of From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease]. Diabetes, 54(6), 1626. American Diabetes Association. https://doi.org/10.2337/diabetes.54.6.1626
